title: Misleading congress about drug development: Reply.
abstract: The review essay by Donald Light about a Congressional Budget Office report on pharmaceutical research and development (R&D) (Light 2007) contains factual errors, leaves the reader uninformed about rebuttal responses to criticisms made in the review about studies of R&D costs, and draws erroneous conclusions about the nature of industry economics.
authors.affiliation: Tufts University.
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Dimasi
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Hansen
authors.forename: Henry G
authors.initials: HG
authors.lastname: Grabowski
mesh_terms: D035843:Biomedical Research / Q000191:economics*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence* / Q000458:organization & administration; D006801:Humans; D011057:Politics; D014481:United States